公司资料
National Research Corporation 股价、新闻与催化剂
- 股票代码:
- NRC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
21.77 USD (+2.74%)
收盘价
最后更新: 2026年8月17日
441M USD
市值
股价为何变动
As of Aug 17, 2026, NRC closed up 2.74% at $21.77. No new same-company headline was identified in the current news window.
公司概览
业务概览
National Research Corporation is a healthcare analytics and experience company focused on measuring and improving patient, employee, and consumer outcomes. Its business is centered on data and analytics rather than biotech.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, National Research sits in healthcare information services.
商业模式特征
The company generates revenue through software, analytics, and subscription-based measurement tools for healthcare organizations.
生物医药行业定位
National Research is outside biotech and belongs to the healthcare-data layer where software adoption matters most.
未来催化剂
- National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact. A stable renewal picture would help confirm the business is still behaving like a durable software franchise.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。